We provide you with 20 years of free, institutional-grade data for PALI stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of PALI. Explore the full financial landscape of PALI stock.
| Reported Date | CIK | Ticker | Type |
|---|
Palisade Bio Inc(NASDAQ:PALI) 
Palisade Bio, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on discovering, developing, and commercializing oral therapies that target diseases associated with the breakdown of the mucosal barrier protecting the gastrointestinal (GI) tract.
Website: https://senecabio.com/
Founded: 2005
CEO: Kenneth Carter
Sector: Manufacturing
Industry: Biological Product (except Diagnostic) Manufacturing
Share this website to your friends
The information provided in this report about PALI stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.